impairment

Related by string. impairments * * goodwill impairment charge . impairment charges . impairment charge . hefty goodwill impairment . goodwill impairment . mild cognitive impairment . visual impairment . Goodwill impairment . visual impairments . temporary impairments . goodwill impairments . Goodwill impairment charge . shutdowns asset impairments . asset impairment *

Related by context. All words. (Click for frequent words.) 81 impairments 70 Marcelle Marci Thibault 67 impairment charges 67 Impairment 66 impairment charge 62 asset impairment 62 goodwill impairment 62 Impairments 61 intangible assets 61 impaired 60 intangible asset impairments 60 asset impairments 59 intangible assets impairment 59 intangibles impairment 59 amortizable intangible assets 59 temporary impairments 58 Textphone +# 0 58 intangible impairment 58 goodwill impairments 58 intangible asset 58 goodwill impairment charge 58 identifiable intangibles 57 textphone minicom 56 identifiable intangible assets 56 unrealized derivative gain 56 hedge ineffectiveness 55 OTTI 54 goodwill intangible 54 noncash impairments 54 noncash goodwill 54 Caffeine reverses memory 53 unrealized losses 53 unrealized gains 53 unrealized derivative 52 OTTI charge 52 OTTI charges 52 AMF Ultra Short 52 cognitive impairment 51 Re eng 51 Harland Clarke tradename 51 valuation adjustments 51 noncash impairment 51 Goodwill impairment 51 temporary impairment OTTI 51 excluding depreciation depletion 51 uncollectible accounts receivable 51 neurologic dysfunction 51 noncash pretax 50 Impaired 50 section staffers quaff 50 OTTI write downs 50 net realizable 50 noncash goodwill impairment 50 unconsolidated subsidiaries 50 unrealized derivative gains 50 debt extinguishments 50 depreciable assets 50 identifiable intangible 50 write downs 50 unevaluated properties 50 nonrecurring items 50 precursor mild cognitive 50 OREO valuation 49 amortization 49 realizability 49 temporary impairments OTTI 49 cognitive impairments 49 writedown 49 d Represents 49 inventory write downs 49 noncash impairment charge 49 amortization expense 49 debt extinguishment 48 f Reflects 48 discontinued operations 48 remeasurement 48 Alcott Routon intangible assets 48 unrealized depreciation 48 unamortized deferred 48 FDIC indemnification 48 DAC unlock 47 asset write downs 47 pretax goodwill impairment 47 asset valuation allowance 47 f Represents 47 LAE reserves 47 Asset impairments 47 IAROC 47 intangibles amortization 47 severance accruals 47 c Includes 47 valuation allowance 47 asset impairments restructuring 47 MSR hedging 47 nonrecurring expenses 47 repetitious behaviors 47 SunPower incurs amortization 47 neurological impairment 47 OREO properties 47 Valuation allowance 47 unamortized 47 doubtful accounts receivable 46 noncash accounting 46 marketable securities 46 #,#.# #,#.# Intangible assets 46 Identifiable intangible assets 46 repossessed assets 46 accrual 46 infrequently occurring 46 audiometric 46 Realized gains 46 undiscounted cash 46 Purchased intangible assets 46 decrements 46 Other Intangible Assets 46 unrealized 46 aftertax gain 46 Adjusted EBITDA excludes 46 Intangible assets 46 amortizable 46 early extinguishments 46 unproved properties 46 pretax 46 mild cognitive 46 early extinguishment 46 non recurring 46 realizable value 46 Write downs 46 neurosensory 46 unfavorable variance 46 OREO write downs 46 uncollectible receivables 46 accretion expense 46 paralysis blindness 46 noncash amortization 45 amortized cost 45 Visa indemnification 45 derivative liabilities 45 c Represents 45 GSCT program 45 Accelerated depreciation 45 owned OREO 45 LIFO adjustments 45 Impairment Charges 45 noninterest expense decreased 45 unrealized gain 45 pension curtailment 45 cerebral palsy mental retardation 45 accounts receivable balances 45 accruals 45 Surface Specialties acquisition 45 intangible impairments 45 FHLMC preferred stock 45 Excluding goodwill impairment 45 Unizan merger 45 b Includes 45 SFAS No. 45 Real Estate Owned OREO 45 abnormalities 45 lease terminations 45 Accounting Guideline AcG 45 unconsolidated investee 45 noncash 45 unamortized deferred financing 45 compensation expense 45 acquired intangible assets 45 EBIAT 45 Abandonments 45 aftertax charge 45 intangibles 45 non cancelable lease 45 - Adjusted [028] 44 depreciation accretion 44 Writedown 44 #,#,# #,#,# Impairment 44 multi infarct dementia 44 MSRs 44 presbycusis 44 Efficiency ratio excluding 44 investees partially offset 44 Sensorineural hearing loss 44 Than Temporarily Impaired 44 extrapyramidal 44 MSR impairment 44 cognitive deficits 44 cognitive dysfunction 44 unamortized issuance costs 44 unamortized premiums 44 nonoperating expense 44 depreciation amortization 44 cerebral palsy blindness 44 Restructuring impairment 44 nonconsolidated affiliate 44 vascular cognitive impairment 44 -Josephine Marcotty 44 Noncash 44 Noninterest expense decreased 44 Than Temporary Impairment 44 Adjustments Amortization 44 FDIC indemnification asset 44 cognitive 44 goodwill writedown 44 Unrealized gains 44 Mild cognitive impairment 44 nonroutine income 44 SFAS No.# 44 Derivative Liabilities 44 cortical blindness 44 LIFO inventory valuation 44 untreated obstructive sleep 44 unamortized debt 44 Pro forma adjustments 44 chromatic dispersion CD 44 impaired cognition 44 unamortized discount 44 irreversible neurological 44 Fundo Wheels 44 valuation allowances 44 MSR valuation 44 derivative instrument 44 intercompany loans 44 noncash unrealized 44 non amortizing intangible 44 cognitive dysfunctions 44 OSIs 44 unamortised 44 depreciation amortization impairment 44 dysarthria 44 Impairment Charge 44 unrealized appreciation 44 hypomanic episode 43 nonrecurring 43 postretirement benefit 43 Addback Depreciation 43 mild retardation 43 tremors stiffness slowness 43 Mental retardation 43 nystagmus 43 Excludes goodwill 43 b Reflects 43 psychosocial functioning 43 Intangible asset 43 noncurrent assets 43 pretax noncash 43 perceptual reasoning 43 old Irma Morado 43 accretable 43 LIFO adjustment 43 OREO 43 depletable base 43 visual impairment 43 exertional 43 SILO LILO charges 43 mental anguish disfigurement 43 preopening expenses 43 receivable 43 write offs 43 unconsciousness unsteadiness problems 43 unrealized gains losses 43 dysphonia 43 akinesia 43 NONRECURRING ITEMS 1 43 AcG 43 mental retardation cerebral palsy 43 deterioration 43 Noise induced 43 habitual snoring 43 exclude noncash 43 nonaccruing loans 43 Excludes depreciation 43 astronaut spaceflight crewmember 43 psychogenic amnesia 43 lightheadedness dizziness 43 noncash charge 43 gait disturbance 43 - -Labyer 43 Excludes amortization 43 impaired OTTI 43 per dilutedshare 43 phonic tics 43 LIFO inventory reserve 43 Asset impairment 43 cognitive perceptual 43 currency remeasurement 43 hypovolemia 43 noncash pretax impairment 43 amortisations 42 ototoxicity 42 parkinsonism 42 inventories revalued 42 Accretion expense 42 somatic symptoms 42 neuro developmental disorder 42 elevated liver enzymes 42 equity method investees 42 cognitive domains 42 amortize goodwill 42 -Ivgi 42 b Excludes 42 c Reflects 42 SFSB transaction 42 Goodwill Impairment 42 Partnered Brands segment 42 DAC unlocking 42 Alzheimer disease mild cognitive 42 Intangibles Goodwill 42 hemiplegia 42 perinatal asphyxia 42 receivable balances 42 loss NOL carryforward 42 unfavorable variances 42 extrapyramidal symptoms 42 b Represents 42 tardive dyskinesia TD 42 premorbid 42 SFAS 42 No. #R 42 -Edelsberg 42 neurological abnormalities 42 Goodwill impairment charge 42 retinitis pigmentosa RP 42 neuropsychological deficits 42 lien RMBS 42 actuarial liabilities 42 dopamine antagonism 42 Accounts receivables 42 nonarteritic anterior ischemic optic 42 loan chargeoffs 42 adopting SFAS #R 42 leasehold improvements 42 MorAmerica Capital 42 Thomas Regout operations 42 - Income [020] 42 sudden sensorineural hearing 42 excluding unrealized gains 42 subordinated CMBS 42 Concateno plc 42 derivative instruments 42 severely impairs 42 cerebral hypoperfusion 42 intangible amortization 42 neuromuscular dysfunction 42 NETg acquisition 42 LIFO accounting 42 involuntary jerking 42 - Adjusted [019] 42 visuospatial skills 42 blindness deafness 42 WWS Divestiture 42 biochemical imbalances 42 macular degeneration glaucoma 42 intercompany balances 42 remeasurements 42 depreciation 42 sensory neuropathy 42 anterior temporal 42 Impairment Losses 42 excludes unrealized gains 42 #,#.# #,#.# Goodwill [002] 42 unallocated expenses 42 c Consists 42 PLEXUS CORP. CONDENSED CONSOLIDATED 42 unrealized hedging 42 macular edema secondary 42 neurological impairments 42 cerebral atrophy 41 cerebral palsy autism 41 Wernicke Korsakoff syndrome 41 nondeductible expenses 41 FSAH Acquisition 41 jaw osteonecrosis 41 Goodwill impairment - [002] 41 Equity Investees 41 neurocognitive functioning 41 unproved leasehold 41 unamortized portion 41 writedowns 41 Interest expense decreased 41 Partially offset 41 depreciation amortization depletion 41 recourse indebtedness 41 Amortization 41 estimated undiscounted 41 pretax noncash charges 41 nerve palsy 41 affective psychoses 41 agnosia 41 unconsolidated affiliate 41 Timeshare segment 41 Derivative instruments 41 Depletion depreciation amortization 41 Foreclosed assets 41 Impaired loans 41 nonroutine 41 FNMA preferred 41 excludes depreciation 41 SRBD 41 - - Nesignandsight newsletter 41 derecognized 41 -Jill Allread partner 41 autonomic dysfunction 41 MMSE score 41 neurodevelopmental outcome 41 - Adjusted [011] 41 Nonoperating 41 commodity derivative instruments 41 Debt Extinguishment 41 LIFO inventory 41 FIN #R 41 neurodevelopmental disorder 41 purchased intangible assets 41 electrolyte disturbances 41 writeoff 41 CTEPH 41 Critical limb ischemia 41 securitized receivables 41 Foreclosed real estate 41 #.#per diluted 41 accelerated depreciation 41 noninterest expenses 41 Reclassification adjustment 41 stock basedcompensation 41 congenital amusia 41 neurodevelopmental outcomes 41 EBITDA EBITDAM EBITDAR 41 perpetual debentures 41 expressive aphasia 41 CTVgm 41 - Adjusted [020] 41 dyspnea shortness 41 neurologic sequelae 41 TEB adjustment 41 Equinix excludes 41 Adjustments Inventory 41 MFB Corp 41 ASC #-#-# 41 postretirement benefit plans 41 taxes EBDDT 41 - INVESTING ACTIVITIES [004] 41 recoverables 41 Supervalu 3Q 41 MtM gains 41 e mailing disastercustomerservice@sba.gov 41 nonoperating income 41 recurrent seizures 41 Intangible amortization 41 #.# perdiluted 41 extinguishment 41 dysphasia 41 treating psychiatric disorders 41 UPDRS Part III 41 maturational 41 adequately collateralized 41 Chronic insomnia 41 unconsolidated investments 41 fatigue blurred vision 41 postretirement obligations 41 disorders FASD 41 cerebrovascular accident 41 psychiatric comorbidity 41 translation adjustment 41 neuropsychological impairments 41 psychomotor skills 41 Knee osteoarthritis 41 neuropsychiatric disorder 41 IBNR reserve 41 psychosocial variables 41 Depressive symptoms 41 noninterest expense 41 activates closed captioning 41 distort comparability 41 Diabetic retinopathy 41 da mage 41 telogen effluvium 41 neurological dysfunction 41 depreciable real estate 41 Asset Impairment 41 Positively impacting 41 LPT Agreement 41 Unrealised 41 paraesthesia 41 daytime drowsiness 41 depletion depreciation 41 Other assets# [001] 41 Debt extinguishment costs 40 reinsurance commutations 40 EURO#.# [002] 40 ALLL 40 postretirement 40 amortized 40 Acquired intangibles 40 subjective sleepiness 40 Restructuring asset impairments 40 depreciable asset 40 BioMarin Genzyme LLC 40 TMJD 40 Consolidated Adjusted EBITDA 40 carryforwards 40 Than Temporary Impairments 40 Unrealized 40 notes receivable 40 MSEK -# [002] 40 discount accretion 40 uncorrected vision 40 sleep disturbances 40 Total noninterest expenses 40 Adjustments Impairment 40 expensed 40 Anxiety disorders 40 Non recurring 40 diagnose clinically 40 LOCOM 40 neuropsychological functioning 40 neurocognitive disorder 40 Mayne Pharma intangible assets 40 hypoglycemic episodes 40 adjusted EBITDAR 40 accrual reversal 40 behavioral disturbances 40 EBITDARM 40 deposit intangible 40 dispositions 40 involuntary movements 40 coronary stenosis 40 deficiency 40 deductible goodwill impairment 40 ADLs 40 b Relates 40 flow hedges 40 associatedwith 40 ASC #-# 40 liabilities 40 OxyVinyls 40 metabolic acidosis 40 equity investee 40 Octane Additives 40 amyloid pathology 40 USD'# 40 -Gottron 40 Retinal vein occlusion 40 Asset Retirement Obligation 40 syncope 40 coughing shortness 40 Reported Unaudited Condensed 40 accretion DD & 40 Loss Gain 40 SEK -#.# -#.# [003] 40 continuingoperations 40 anemia neutropenia 40 Cognitive impairment 40 j Includes 40 inventory obsolescence 40 inattention hyperactivity 40 postural instability 40 elevated IOP 40 neurologic symptoms 40 olfactory dysfunction 40 reclass 40 Currency fluctuation 40 Oilseeds Processing 40 SEK -#.# [002] 40 Reconciling Items 40 neuropathies 40 neurocognitive deficits 40 Unrealized derivative 40 profitsharing 40 -READFIELD Maine 40 Specified Items 40 psychomotor 40 EUR -#.# -#.# [001] 40 noncurrent liabilities 40 parkinsonian 40 operatingincome 40 sensorineural hearing loss 40 Goodwill #,#.# #,#.# 40 Debt extinguishments 40 intersegment transactions 40 Inventory writedown 40 dopaminergic therapy 40 Unusual Items 40 incurs amortization 40 intersegment eliminations 40 d Reflects 40 Compensation Expenses 40 Depreciations 40 unamortized financing 40 baroreceptor reflex 40 cochlear implantation 40 Adjusted OIBDA excludes 40 Acquired Intangible Assets 40 Ebstein anomaly 40 Other Specified Items 40 Negatively impacting 40 neuropsychiatric symptoms 40 impairs 40 adjustment 40 - Adjusted [010] 40 uncollectible reinsurance 40 directly indirectly consequentially 40 Diabetic neuropathy 40 assets# [002] 40 NOL utilization 40 posterior vitreous detachment 40 goodwill amortization 40 c Excludes 40 dizziness shortness 40 Chronic bronchitis 40 Intangibles net 40 unsteadiness 40 dysgraphia 40 securitized cardmember loans 40 aftertax 40 - Adjusted [029] 40 atypical parkinsonism 40 PDE 5i 40 - Adjusted [009] 40 - Total noninterest expense 40 -Tioman 40 clinically meaningful improvements 40 deafness 40 mania hypomania 40 ATCF 40 LIFO reserve 40 unamortized balances 40 Pro forma EPS 40 materially misstated 40 #,# -inch #:# widescreen 40 generalized tonic clonic seizures 40 reasonably estimable 40 CIC convertible debenture 40 depletion calculation 40 vestibular dysfunction 40 Real Estate Owned 40 behavioral abnormalities 40 nonaccrual loan 40 apneic 40 psychiatric comorbidities 40 excluding MSRs 40 extrapyramidal symptoms EPS 40 hemiparesis 40 brain lesions 40 refractive error 40 Noninterest expenses 40 ended September# 40 hippocampal atrophy 40 Depreciation depletion amortization 40 depression irritability 40 Intangible asset impairments 40 undernoted items 40 vestibular disorders 40 motor peripheral neuropathy 40 noncash pretax charge 40 OPEB expense 40 Meniere disease 40 cognitive decline 40 optic neuropathy NAION 40 CDO exposures 40 Mood disorders 40 sensory disturbances 40 SNHL 40 Compulsive hoarding 40 thirst urination 40 Items impacting comparability 40 APOE genotype 40 neurocognitive function 40 daytime sleepiness 40 neurologic deficits 40 Exclusion criteria 40 invoiced shipment 39 loss 39 Intangibles amortization 39 painful diabetic peripheral 39 VaD 39 acquired intangibles 39 Urge incontinence 39 Dhs1 #m 39 alexithymia 39 nonaccrual loans 39 -Bellevarde mountain 39 EBITDAO 39 audiogram 39 physiological reactions 39 headaches nausea vomiting 39 Covered Loans 39 chronic neurological disorder 39 Amortized 39 daytime alertness 39 - Adjusted [001] 39 LIFO expense 39 - Operating [028] 39 noncash writedown 39 elevated homocysteine 39 sustained ventricular tachycardia 39 Long Lived Asset 39 neurodevelopmental disability 39 recoverability 39 FSAH acquisition 39 depressive symptomatology 39 mild mental retardation 39 obsolete inventory 39 accretion 39 - Income [002] 39 netincome 39 foreign currency remeasurement 39 unfavorably impacted 39 audiometry 39 uncorrected refractive error 39 Asset Impairment Charge 39 NATRECOR 39 muscular degeneration 39 Xceed Mortgage Trust 39 disorder ASD 39 excluding depreciation amortization 39 ischemic optic neuropathy 39 -beachside Costera Miguel Aleman 39 uncollectable receivables 39 depreciations 39 Excluding nonrecurring items 39 tradenames 39 androgen depletion 39 No. #R SFAS 39 Vascular dementia 39 contractual minimums 39 hypopituitarism 39 Add subtract 39 Obstructive sleep apnea OSA 39 super recognizers 39 developmental delays 39 unabsorbed manufacturing 39 incurred 39 Qualcomm Strategic Initiatives 39 tics involuntary 39 Non Current Assets 39 Filtran Microcircuits Inc. 39 - - Net [003] 39 AOCL 39 cause drowsiness dizziness 39 Unrealized foreign 39 disability 39 LibertyBank Acquisition 39 #,# -oxidative enzymes 39 Down syndrome cerebral palsy 39 - Adjusted [003] 39 - Adjusted [007] 39 Intangible amortization expense 39 - - Non GAAP [002] 39 excluding nonrecurring 39 cerebral palsy Down syndrome 39 apneic episodes 39 PLRMBS 39 Dropdown Predecessor 39 Repossessed assets 39 Long Lived Assets 39 Loss 39 headache nausea vomiting 39 prepayment speeds loan originations 39 Korsakoff syndrome 39 alkalosis 39 convulsive seizures 39 Purchased intangibles 39 NOL carryforwards 39 neurologic impairment 39 Normalised earnings 39 incoordination 39 Unusual Items section 39 motor tics 39 Remeasurement 39 NOI decreased 39 - Operating [026] 39 - - Non GAAP [008] 39 irritability tremors 39 -BY LESLIE BIXLER • 39 appetite lethargy 39 - Income [017] 39 atrophic gastritis 39 muscular rigidity 39 Goodwill #,#,# #,#,# [002] 39 photokeratitis 39 unexplained shortness 39 QTc prolongation 39 g Represents 39 Tikcro holdings 39 Incurred losses 39 syndrome FAS 39 profound deafness 39 Background Screening segment 39 hirsutism 39 FIFO inventory 39 - Adjusted [024] 39 Nitram backlog 39 chest pains shortness 39 Noncurrent liabilities 39 unallocated corporate 39 confusional 39 deferred loan origination 39 deferred 39 Excessive daytime sleepiness 39 -Andrew Mayeda Postmedia News 39 - Adjusted [006] 39 HBV infections 39 consolidated balance sheet 39 airway obstruction 39 Intangible Assets Net 39 Interest expense 39 airflow limitation 39 disposition 39 Chronic sleep deprivation 39 nonaccidental trauma 39 pro forma adjusted EBITDA 39 confusion disorientation 39 readily determinable 39 injury permanent disfigurement 39 - - Income [022] 39 - - NetMarigot Bay r 39 psychopathological disorders 39 subjective determinations 39 repetitive stereotyped 39 neuropsychological assessments 39 hyperactivity impulsivity 39 events TEAEs 39 dizziness sleepiness 39 Adjustments Restructuring 39 - InFree Documentation License 39 oxygen desaturation 39 - Adjusted [016] 39 Oxypurinol 39 c Relates 39 APOE e4 39 undernoted 39 unabsorbed overhead 39 Including discontinued operations 39 - Loss [034] 39 -Inc. NASDAQ CHTR 39 Restructuring 39 neurobehavioural 39 myopia nearsightedness 39 ChannelRe 39 blind deafblind 39 nonaccruing 39 Bois d' Arc's 39 excludes noncash 39 Sleep disordered breathing 39 mood dysregulation 39 multivariate adjustment 39 Movado boutiques 39 inherited neurological disorder 39 NIHSS score 39 detrusor overactivity 39 - Loss [013] 39 unprovoked seizures 39 akinetic mutism 39 elevated LDH 39 liabilities #,#,# [001] 39 unproved acreage 39 Foreclosed Assets 39 adverse 39 macular holes 39 pupil dilation 39 TBtu 39 TRUPs 39 charge offs 39 Timberland disposals net 39 dysrhythmias 39 -Celine Dion Eric Clapton 39 disorders 39 amblyopic 39 hedging instruments 38 hydrops 38 Neurobionix 38 uncollectible accounts 38 neurologic abnormalities 38 Discontinued Operations 38 - Adjusted [005] 38 undepreciated 38 cognitive function 38 MSEK -# [001] 38 loss carrybacks 38 nonaccruals 38 Equity investee 38 Nonrecurring 38 Non GAAP adjusted EBITDA 38 -lipid nanoparticles 38 anosmia 38 Maritech 38 Purchased intangibles net 38 Secondhand smoke exposure 38 neuro developmental 38 muscular spasticity 38 losses ALLL 38 writebacks 38 undiscounted 38 Down syndrome autism 38 impairing 38 nonaccrual 38 apraxia 38 postretirement benefits 38 debilitating neurodegenerative disorder 38 anticholinergic effects 38 currency translation 38 Depreciation Depletion Amortization 38 COLLEAGUE infusion pump 38 Beta coefficient 38 alveolar bone loss 38 -Tilak Marg 38 idiopathic PD 38 neuropsychological assessment 38 TOTAL OTHER INCOME EXPENSE 38 Unallocated expenses 38 tremor stiffness slowness 38 paresthesia 38 delusions hallucinations 38 EBITDAF 38 thyroid dysfunction 38 amort 38 mild cognitive impairments 38 - Loss [022] 38 fatigue shortness 38 impacting comparability 38 hippocampal volume 38 Pretax 38 headaches dizzy spells 38 -Alcampo 38 poststroke 38 FAS #R expense 38 psychomotor retardation 38 Lewy bodies DLB 38 ceded reinsurance 38 autism dyslexia 38 purchased intangibles 38 - Adjusted [025] 38 business acquired VOBA 38 hyposmia 38 cough shortness 38 COS Restructuring 38 chronic venous insufficiency 38 FAS CAS pension 38 visual hallucinations 38 FASB Statement #R 38 fiscal# 38 debt restructurings TDRs 38 cerebral vascular accident 38 TEAEs 38 Alzheimer disease vascular dementia 38 USD#.#m USD#.# per [002] 38 clinically meaningful improvement 38 incentive accruals 38 Asset Retirement Obligations 38 torticollis 38 Diluted EPS attributable 38 CDFS 38 Catastrophe losses 38 -mintages 38 Possible Loan Losses 38 - - Net [047] 38 arterial thromboembolic events 38 visuospatial 38 affective psychosis 38 ADCS ADL 38 Embedded Derivatives 38 lability 38 NonInterest expense 38 intercompany receivables 38 - -Guldeniz 38 Usher Syndrome 38 unexplained syncope 38 testicular tumors 38 - - Total [007] 38 Mortgage Servicing Rights 38 atrial tachyarrhythmias 38 aMCI precursor 38 Intangible assets Goodwill 38 -Vallipunam 38 cannabis induced psychosis 38 Amortiz 38 excessive salivation 38 prolactin levels 38 economically recoverable reserves 38 dizziness blurred vision 38 involuntary twitching 38 millioncompared 38 cognitive abilities 38 -Mr Devani 38 - - Income [012] 38 neurobehavioral disorder 38 anticholinergic medication 38 monoline exposure 38 airway obstructions 38 specially serviced assets 38 Subordinate MBS 38 - NeDEFENDERS 38 Discontinued operations 38 audiologic 38 tinnitus ringing 38 enlarged ventricles 38 tiredness shortness 38 dizziness nausea headaches 38 thyroid deficiency 38 divestitures 38 neurocognitive

Back to home page